Cargando…
Galectin-9 protects humanized-ACE2 immunocompetent mice from SARS-CoV-2 infection
SARS-CoV-2 remains a global health crisis even with effective vaccines and the availability of FDA approved therapies. Efforts to understand the complex disease pathology and develop effective strategies to limit mortality and morbidity are needed. Recent studies reveal circulating Galectin-9 (gal-9...
Autores principales: | Yeung, Stephen T., Premeaux, Thomas A., Du, Li, Niki, Toshiro, Pillai, Satish K., Khanna, Kamal M., Ndhlovu, Lishomwa C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621319/ https://www.ncbi.nlm.nih.gov/pubmed/36325323 http://dx.doi.org/10.3389/fimmu.2022.1011185 |
Ejemplares similares
-
Galectin-9 Mediates HIV Transcription by Inducing TCR-Dependent ERK Signaling
por: Colomb, Florent, et al.
Publicado: (2019) -
Human galectin-9 potently enhances SARS-CoV-2 replication and inflammation in airway epithelial cells
por: Du, Li, et al.
Publicado: (2023) -
Emerging Insights on Caspases in COVID-19 Pathogenesis, Sequelae, and Directed Therapies
por: Premeaux, Thomas A., et al.
Publicado: (2022) -
Role of Natural Killer Cells in HIV-Associated Malignancies
por: Leal, Fabio E., et al.
Publicado: (2017) -
Human Galectin-9 Is a Potent Mediator of HIV Transcription and Reactivation
por: Abdel-Mohsen, Mohamed, et al.
Publicado: (2016)